H1BDataPointPublic data. Better decisions.
COMPANY SALARY EXPLORER

Novartis Gene Therapies, Inc.

Exact employer profile · All loaded years

Clear filters
Matching filings24
Median yearly base wage$97,136n=24 eligible
Middle 50% of yearly wages$79,664 – $109,793
Most reported worksiteDurham, NC15 matching filings
Explore this companyMost reported roleManufacturing Quality Assurance Specialist Top worksiteDurham Individual recordsInspect dates & base salaries
Explore your way
Inspect, sort and export individual filings.

Salary records

24 matching H-1B filings

Export page CSV

Reported base wages in USD · pay period shown beside each amount · select a salary for case details

EmployerJob titleBase salaryLocationSubmit dateStart date
Novartis Gene Therapies, Inc.Manufacturing Quality Assurance Specialist

Filing details

$98,218 /yr

I-200-25311-390184
Reported wage: $98,218 / year
Annualized: $98,218
Status: Certified
Fiscal year: 2026
Decision: 2025-11-17
Employment end: 2029-04-09
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC11/07/202504/10/2026
Novartis Gene Therapies, Inc.Quality Control Specialist

Filing details

$75,691 /yr

I-200-25269-338870
Reported wage: $75,691 / year
Annualized: $75,691
Status: Certified
Fiscal year: 2026
Decision: 2025-11-05
Employment end: 2029-03-26
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC09/26/202503/27/2026
Novartis Gene Therapies, Inc.Sr Engineer, Manufacturing Science &Tech

Filing details

$112,757 /yr

I-200-25246-283053
Reported wage: $112,757 / year
Annualized: $112,757
Status: Certified
Fiscal year: 2025
Decision: 2025-09-10
Employment end: 2029-02-28
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC09/03/202503/01/2026
Novartis Gene Therapies, Inc.Specialist, Quality Control

Filing details

$84,344 /yr

I-200-25150-034310
Reported wage: $84,344 / year
Annualized: $84,344
Status: Certified
Fiscal year: 2025
Decision: 2025-06-06
Employment end: 2028-10-23
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC05/30/202510/24/2025
Novartis Gene Therapies, Inc.Specialist, Quality Control It

Filing details

$112,320 /yr

I-200-25119-918670
Reported wage: $112,320 / year
Annualized: $112,320
Status: Certified
Fiscal year: 2025
Decision: 2025-05-06
Employment end: 2028-10-23
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC04/29/202510/24/2025
Novartis Gene Therapies, Inc.Senior Specialist, Quality Assurance

Filing details

$92,206 /yr

I-200-24284-400018
Reported wage: $92,206 / year
Annualized: $92,206
Status: Certified
Fiscal year: 2025
Decision: 2024-10-18
Employment end: 2028-04-10
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC10/10/202404/11/2025
Novartis Gene Therapies, Inc.Manufacturing Quality Assurance Specialist

Filing details

$78,874 /yr

I-200-23087-882871
Reported wage: $78,874 / year
Annualized: $78,874
Status: Certified
Fiscal year: 2023
Decision: 2023-04-04
Employment end: 2026-04-09
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC03/28/202304/10/2023
Novartis Gene Therapies, Inc.Manufacturing Quality Assurance Specialist

Filing details

$78,874 /yr

I-200-23080-864648
Reported wage: $78,874 / year
Annualized: $78,874
Status: Certified
Fiscal year: 2023
Decision: 2023-03-28
Employment end: 2026-04-09
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC03/21/202304/10/2023
Novartis Gene Therapies, Inc.Engineer, Manufacturing Science And Technology

Filing details

$99,466 /yr

I-200-23069-838601
Reported wage: $99,466 / year
Annualized: $99,466
Status: Certified
Fiscal year: 2023
Decision: 2023-03-17
Employment end: 2026-03-20
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC03/10/202303/21/2023
Novartis Gene Therapies, Inc.Senior Analyst, Quality Control

Filing details

$73,050 /yr

I-200-23067-831629
Reported wage: $73,050 / year
Annualized: $73,050
Status: Certified
Fiscal year: 2023
Decision: 2023-03-15
Employment end: 2026-03-26
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC03/08/202303/27/2023
Novartis Gene Therapies, Inc.Senior Engineer, Manufacturing Science

Filing details

$115,482 /yr

I-200-22273-505190
Reported wage: $115,482 / year
Annualized: $115,482
Status: Certified
Fiscal year: 2023
Decision: 2022-10-07
Employment end: 2026-02-25
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Libertyville, IL09/30/202202/26/2023
Novartis Gene Therapies, Inc.Specialist, Quality Control

Filing details

$108,950 /yr

I-200-22272-502271
Reported wage: $108,950 / year
Annualized: $108,950
Status: Certified
Fiscal year: 2023
Decision: 2022-10-06
Employment end: 2025-10-23
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC09/29/202210/24/2022
Novartis Gene Therapies, Inc.Senior Engineer, Manufacturing Science And Technology

Filing details

$106,642 /yr

I-200-22125-138816
Reported wage: $106,642 / year
Annualized: $106,642
Status: Certified
Fiscal year: 2022
Decision: 2022-05-12
Employment end: 2025-10-16
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Libertyville, IL05/05/202210/17/2022
Novartis Gene Therapies, Inc.Senior Project Manager, Manufacturing Science And Technology

Filing details

$100,838 /yr

I-200-22112-097122
Reported wage: $100,838 / year
Annualized: $100,838
Status: Certified
Fiscal year: 2022
Decision: 2022-04-29
Employment end: 2025-05-01
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC04/22/202205/02/2022
Novartis Gene Therapies, Inc.Quality Control Microbiology Supervisor

Filing details

$154,856 /yr

I-200-22104-071346
Reported wage: $154,856 / year
Annualized: $154,856
Status: Certified
Fiscal year: 2022
Decision: 2022-04-21
Employment end: 2025-04-24
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC04/14/202204/25/2022
Novartis Gene Therapies, Inc.Specialist, Quality Assurance - Quality Control

Filing details

$79,414 /yr

I-200-22075-983603
Reported wage: $79,414 / year
Annualized: $79,414
Status: Certified
Fiscal year: 2022
Decision: 2022-03-23
Employment end: 2025-04-10
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC03/16/202204/11/2022
Novartis Gene Therapies, Inc.Bio Process Engineer Ii

Filing details

$89,045 /yr

I-200-21362-789238
Reported wage: $89,045 / year
Annualized: $89,045
Status: Certified
Fiscal year: 2022
Decision: 2022-01-05
Employment end: 2025-01-02
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Libertyville, IL12/28/202101/03/2022
Novartis Gene Therapies, Inc.Director, Global Real-World Evidence

Filing details

$141,378 /yr

I-200-21294-658773
Reported wage: $141,378 / year
Annualized: $141,378
Status: Certified
Fiscal year: 2022
Decision: 2021-10-28
Employment end: 2024-10-31
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Ridgewood, NJ10/21/202111/01/2021
Novartis Gene Therapies, Inc.Business Systems Analyst

Filing details

$79,747 /yr

I-200-21106-231938
Reported wage: $79,747 / year
Annualized: $79,747
Status: Certified
Fiscal year: 2021
Decision: 2021-04-23
Employment end: 2024-09-23
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Deerfield, IL04/16/202109/24/2021
Novartis Gene Therapies, Inc.Process Science Engineer Iii

Filing details

$83,741 /yr

I-200-21089-184677
Reported wage: $83,741 / year
Annualized: $83,741
Status: Certified
Fiscal year: 2021
Decision: 2021-04-06
Employment end: 2024-09-02
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

San Diego, CA03/30/202109/03/2021
Novartis Gene Therapies, Inc.Senior Project Manager, Manufacturing Science And Technology

Filing details

$103,646 /yr

I-200-21083-170718
Reported wage: $103,646 / year
Annualized: $103,646
Status: Certified
Fiscal year: 2021
Decision: 2021-03-31
Employment end: 2024-08-25
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Durham, NC03/24/202108/26/2021
Novartis Gene Therapies, Inc.Manufacturing Quality Associate

Filing details

$63,856 /yr

I-200-21060-110457
Reported wage: $63,856 / year
Annualized: $63,856
Status: Certified
Fiscal year: 2021
Decision: 2021-03-08
Employment end: 2024-03-14
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Libertyville, IL03/01/202103/15/2021
Novartis Gene Therapies, Inc.Associate Director, Regions Global Regulatory Affairs

Filing details

$169,542 /yr

I-200-20345-949455
Reported wage: $169,542 / year
Annualized: $169,542
Status: Certified
Fiscal year: 2021
Decision: 2020-12-17
Employment end: 2023-12-20
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Bannockburn, IL12/10/202012/21/2020
Novartis Gene Therapies, Inc.Business Systems Analyst 2

Filing details

$96,054 /yr

I-200-20346-952027
Reported wage: $96,054 / year
Annualized: $96,054
Status: Certified
Fiscal year: 2021
Decision: 2020-12-17
Employment end: 2023-12-16
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

North Royalton, OH12/10/202012/17/2020

About Novartis Gene Therapies, Inc. H-1B salary records

This view contains 24 matching filings across all loaded fiscal years. The median reported yearly base wage is $97,136, based on 24 certified filings with positive yearly pay. These are filing-level observations, not unique employees or total compensation.

Read each filing in context.

Base wages preserve the disclosed pay period. Select a salary to see its case status, dates, worker positions, and annualized estimate. Salary charts use certified, positive yearly base wages; LCAs are not visa approvals. Subsidiaries and previous legal names have separate profiles. Methodology & coverage ↗